Importantly, not only does the PPP2R2A-/low/Cyclin D1high phenotype add prognostic information to otherwise HER2-expressing luminal BC, it also allows the identification of a subgroup of luminal BC with reduced DFS that would be otherwise classified as luminal A-like. Here, PPP2R2A is linked to breast cancer.